TRAW
Traws Pharma Inc
NASDAQ: TRAW · HEALTHCARE · BIOTECHNOLOGY
$1.43
+10.00% today
Updated 2026-04-30
Market cap
$11.58M
P/E ratio
1.39
P/S ratio
4.15x
EPS (TTM)
$0.82
Dividend yield
—
52W range
$1 – $3
Volume
0.2M
Traws Pharma Inc (TRAW) Financial statements
SEC filings — annual and quarterly data.
Profit margin
328.70%
Operating margin
-641.00%
ROE
-1,060.00%
ROA
-62.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | $1.49M | $-30.31M | 100.00% | -1,854.27% | -2,038.60% |
| 2012 | $46.19M | $-33.87M | 99.31% | -48.23% | -73.32% |
| 2013 | $4.75M | $-64.86M | 100.00% | -1,309.11% | -1,364.67% |
| 2014 | $800000.00 | $-63.68M | 100.00% | -7,968.00% | -7,960.25% |
| 2015 | $11.46M | $-23.98M | 100.00% | -209.25% | -209.31% |
| 2016 | $5.55M | $-19.67M | 100.00% | -427.39% | -354.62% |
| 2017 | $787000.00 | $-24.09M | 100.00% | -3,270.27% | -3,061.25% |
| 2018 | $1.23M | $-20.57M | 100.00% | -1,895.93% | -1,675.33% |
| 2019 | $2.18M | $-21.50M | 100.00% | -994.00% | -985.02% |
| 2020 | $231000.00 | $-25.16M | 100.00% | -10,819.48% | -10,890.48% |
| 2021 | $226000.00 | $-16.16M | 100.00% | -7,299.12% | -7,151.77% |
| 2022 | $226000.00 | $-18.96M | 100.00% | -8,684.51% | -8,391.15% |
| 2023 | $226000.00 | $-18.95M | 100.00% | -8,981.42% | -8,384.07% |
| 2024 | $226000.00 | $-54.67M | 94.69% | -21,835.40% | -24,192.04% |
| 2025 | $2.79M | $9.17M | 97.81% | -640.68% | 328.67% |